Veterinary Medicines

Ventipulmin 30 mcg/ml soluzione iniettabile per vacche partorienti

Authorised
  • Clenbuterol hydrochloride
Download as PDF

Product identification

Medicine name:
Ventipulmin 30 mcg/ml soluzione iniettabile per vacche partorienti
Active substance:
  • Clenbuterol hydrochloride
Target species:
  • Cattle (pregnant cow)
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Clenbuterol hydrochloride
    0.03
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle (pregnant cow)
      • Meat and offal
        28
        day
      • Milk
        5
        day
  • Intravenous use
    • Cattle (pregnant cow)
      • Meat and offal
        28
        day
      • Milk
        5
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG02CA91
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Labiana Life Sciences S.A.
Responsible authority:
  • MdS
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 22/02/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."